Company intelligence / Profile preview

Syntr Health Technologies

Irvine, California, United Statessyntrhealth.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

The company’s flagship product, the SyntrFuge System, has received FDA clearance and enables automated in-office processing of autologous fat for use in body contouring and reconstructive procedures. Clinical adoption has begun with expansion into additional surgical specialties underway.

Therapeutic areas: OtherOncologyDermatology
Modalities: Device (automated fat processing system)Autologous cell therapy (using patient's own adipose tissue)
Industry: Surgical Medical Devices

Partnerships

None publicly disclosed as major pharma/biotech partnerships. The company collaborates with clinicians and academic advisors from various universities.

Beyond the preview

Go deeper on Syntr Health Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntr Health Technologies.

Explore the full profile